Thirty-day readmission following hospitalization for pneumonia is common in patients with underlying comorbidities such as COPD, kidney and heart diseases, and dementia.
All articles by Pulmonology Advisor Contributing Writer
Macrolide monotherapy may be a better choice than inhaled corticosteroids to prevent acute and hospitalized respiratory infections in older patients with bronchiectasis and without COPD or asthma.
Treating severe community-acquired pneumonia with a combination of corticosteroids and antibiotics may be a cost-effective strategy.
Previous antibiotic use and mechanical invasive ventilation were risk factors for multidrug-resistant pathogens in hospital-associated or ventilator-associated pneumonia.